/

Società

As

Non verificato

Asahi Kasei

Di cosa scriviamo

IndustriaMultimedialitàScienzaTecnicaTecnologie Varie

45 comunicati stampa

Guarda tutti i comunicati

20/04/2026

Asahi Kasei Completes Acquisition of Aicuris to Advance Its Global Pharmaceutical Strategy

Fonte

Emittente

1.00

0

20/04/2026

Industria

Salute

Medicina - Varie

Scienza

Farmaceutica

Biotecnologia

Asahi Kasei Announces Initiation of Phase I Clinical Trial for Novel Peptide Candidate Targeting Autoimmune Diseases

Fonte

Emittente

1.00

0

09/04/2026

Breakthrough in PCSEL Optical Sensing Technology by Asahi Kasei Microdevices Enables 2 µm-Band Infrared Laser Generation

Fonte

Emittente

1.00

0

19/03/2026

Tanahashi Prize Recognizes the Robust Long-Term Operation of the 10MW Alkaline-Water Electrolysis System by Asahi Kasei

Fonte

Emittente

1.00

0

25/02/2026

Asahi Kasei Pharma Strengthens Preclinical Pipeline Through Exclusive Global License Agreement with Alchemedicine for Novel Lead Compounds

Fonte

Emittente

1.00

0

18/02/2026

Asahi Kasei Pharma and Alchemedicine Advance a Novel Therapeutic Candidate Into Phase I Study for the Treatment of Refractory Diseases

Fonte

Emittente

1.00

0

29/01/2026

Asahi Kasei Develops PFAS-Free PA66 Offering Low-Friction and High-Load Performance

Fonte

Emittente

1.00

0

27/01/2026

Asahi Kasei, Mitsui Chemicals, and Mitsubishi Chemical enter basic agreement to promote decarbonization of ethylene production in western Japan

Fonte

Emittente

1.00

0

13/01/2026

Senseair launches next-generation CO2 sensor featuring 75% smaller size and SMD-solderability for demand-controlled HVAC systems

Fonte

Emittente

1.00

0

08/01/2026

ZOLL Strengthens Growth Trajectory for Asahi Kasei’s Healthcare Sector with U.S. Launch of the Next-Generation LifeVest® WCD and Rollout of the Most Comfortable LifeVest Garment Ever, Reinforcing Position as Leader in WCD Category

Fonte

Emittente

1.00

0

Seguaci

0

Compatibilità

0